BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, Sahebkar A. Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial. Phytother Res. 2016;30:1540-1548. [PMID: 27270872 DOI: 10.1002/ptr.5659] [Cited by in Crossref: 194] [Cited by in F6Publishing: 181] [Article Influence: 32.3] [Reference Citation Analysis]
Number Citing Articles
1 Shahabipour F, Caraglia M, Majeed M, Derosa G, Maffioli P, Sahebkar A. Naturally occurring anti-cancer agents targeting EZH2. Cancer Letters 2017;400:325-35. [DOI: 10.1016/j.canlet.2017.03.020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
2 Mantzorou M, Pavlidou E, Vasios G, Tsagalioti E, Giaginis C. Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data. Phytother Res. 2018;32:957-975. [PMID: 29468820 DOI: 10.1002/ptr.6037] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 14.8] [Reference Citation Analysis]
3 Shakeri A, Ward N, Panahi Y, Sahebkar A. Anti-Angiogenic Activity of Curcumin in Cancer Therapy: A Narrative Review. CVP 2019;17:262-9. [DOI: 10.2174/1570161116666180209113014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
4 Gerges SH, Wahdan SA, Elsherbiny DA, El-Demerdash E. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sci 2021;271:119220. [PMID: 33592199 DOI: 10.1016/j.lfs.2021.119220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Keihanian F, Saeidinia A, Bagheri RK, Johnston TP, Sahebkar A. Curcumin, hemostasis, thrombosis, and coagulation. J Cell Physiol 2018;233:4497-511. [PMID: 29052850 DOI: 10.1002/jcp.26249] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 10.0] [Reference Citation Analysis]
6 Panahi Y, Kianpour P, Mohtashami R, Atkin SL, Butler AE, Jafari R, Badeli R, Sahebkar A. Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial. Phytotherapy Research 2018;32:1382-7. [DOI: 10.1002/ptr.6073] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
7 Izzo AA. A PTR virtual issue on the experimental and clinical pharmacology of the nutraceutical curcumin. Phytother Res 2018;32:2107-8. [PMID: 30277281 DOI: 10.1002/ptr.6192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Kim HG, Lee SB, Lee JS, Kim WY, Choi SH, Son CG. Artemisia iwayomogi plus Curcuma longa Synergistically Ameliorates Nonalcoholic Steatohepatitis in HepG2 Cells. Evid Based Complement Alternat Med 2017;2017:4390636. [PMID: 29234397 DOI: 10.1155/2017/4390636] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lelli D, Pedone C, Sahebkar A. Curcumin and treatment of melanoma: The potential role of microRNAs. Biomed Pharmacother 2017;88:832-4. [PMID: 28167449 DOI: 10.1016/j.biopha.2017.01.078] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
10 Panahi Y, Mojtahedzadeh M, Najafi A, Rajaee SM, Torkaman M, Sahebkar A. Neuroprotective Agents in the Intensive Care Unit: -Neuroprotective Agents in ICU. J Pharmacopuncture 2018;21:226-40. [PMID: 30652049 DOI: 10.3831/KPI.2018.21.026] [Reference Citation Analysis]
11 Abdollahi E, Momtazi AA, Johnston TP, Sahebkar A. Therapeutic effects of curcumin in inflammatory and immune‐mediated diseases: A nature‐made jack‐of‐all‐trades? J Cell Physiol 2018;233:830-48. [DOI: 10.1002/jcp.25778] [Cited by in Crossref: 144] [Cited by in F6Publishing: 130] [Article Influence: 28.8] [Reference Citation Analysis]
12 Watanabe M, Risi R, Masi D, Caputi A, Balena A, Rossini G, Tuccinardi D, Mariani S, Basciani S, Manfrini S, Gnessi L, Lubrano C. Current Evidence to Propose Different Food Supplements for Weight Loss: A Comprehensive Review. Nutrients 2020;12:E2873. [PMID: 32962190 DOI: 10.3390/nu12092873] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
13 Salahshooh MM, Parizadeh SMR, Pasdar A, Saberi Karimian M, Safarian H, Javandoost A, Ferns GA, Ghayour-mobarhan M, Sahebkar A. The effect of curcumin (Curcuma longa L.) on circulating levels of adiponectin in patients with metabolic syndrome. Comp Clin Pathol 2017;26:17-23. [DOI: 10.1007/s00580-016-2339-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
14 Hosseini A, Sahebkar A. Reversal of Doxorubicin-induced Cardiotoxicity by Using Phytotherapy: A Review. J Pharmacopuncture 2017;20:243-56. [PMID: 30151294 DOI: 10.3831/KPI.2017.20.030] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
15 Saberi-karimian M, Katsiki N, Caraglia M, Boccellino M, Majeed M, Sahebkar A. Vascular endothelial growth factor: An important molecular target of curcumin. Critical Reviews in Food Science and Nutrition 2017;59:299-312. [DOI: 10.1080/10408398.2017.1366892] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
16 Soltani A, Salmaninejad A, Jalili‐nik M, Soleimani A, Javid H, Hashemy SI, Sahebkar A. 5′‐Adenosine monophosphate‐activated protein kinase: A potential target for disease prevention by curcumin. J Cell Physiol 2018;234:2241-51. [DOI: 10.1002/jcp.27192] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
17 Buonomo AR, Scotto R, Nappa S, Arcopinto M, Salzano A, Marra AM, D'Assante R, Zappulo E, Borgia G, Gentile I. The role of curcumin in liver diseases. Arch Med Sci 2019;15:1608-20. [PMID: 31749891 DOI: 10.5114/aoms.2018.73596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Teymouri M, Barati N, Pirro M, Sahebkar A. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential. J Cell Physiol 2018;233:124-40. [PMID: 27996095 DOI: 10.1002/jcp.25749] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
19 Heritage M, Jaskowski L, Bridle K, Campbell C, Briskey D, Britton L, Fletcher L, Vitetta L, Subramaniam VN, Crawford D. Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice. World J Gastrointest Pathophysiol 2017; 8(2): 67-76 [PMID: 28573069 DOI: 10.4291/wjgp.v8.i2.67] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Stati G, Rossi F, Sancilio S, Basile M, Di Pietro R. Curcuma longa Hepatotoxicity: A Baseless Accusation. Cases Assessed for Causality Using RUCAM Method. Front Pharmacol 2021;12:780330. [PMID: 34776989 DOI: 10.3389/fphar.2021.780330] [Reference Citation Analysis]
21 Luangmonkong T, Suriguga S, Mutsaers HAM, Groothuis GMM, Olinga P, Boersema M. Targeting Oxidative Stress for the Treatment of Liver Fibrosis. Rev Physiol Biochem Pharmacol. 2018;175:71-102. [PMID: 29728869 DOI: 10.1007/112_2018_10] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 17.3] [Reference Citation Analysis]
22 Ardalani H, Hadipanah A, Sahebkar A. Medicinal Plants in the Treatment of Peptic Ulcer Disease: A Review. Mini Rev Med Chem 2020;20:662-702. [PMID: 31880244 DOI: 10.2174/1389557520666191227151939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Mohammadian Haftcheshmeh S, Karimzadeh MR, Azhdari S, Vahedi P, Abdollahi E, Momtazi-Borojeni AA. Modulatory effects of curcumin on the atherogenic activities of inflammatory monocytes: Evidence from in vitro and animal models of human atherosclerosis. Biofactors 2020;46:341-55. [PMID: 31875344 DOI: 10.1002/biof.1603] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Mega A, Marzi L, Kob M, Piccin A, Floreani A. Food and Nutrition in the Pathogenesis of Liver Damage. Nutrients 2021;13:1326. [PMID: 33923822 DOI: 10.3390/nu13041326] [Reference Citation Analysis]
25 Sadeghian M, Rahmani S, Jamialahmadi T, Johnston TP, Sahebkar A. The effect of oral curcumin supplementation on health-related quality of life: A systematic review and meta-analysis of randomized controlled trials. J Affect Disord 2021;278:627-36. [PMID: 33038707 DOI: 10.1016/j.jad.2020.09.091] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
26 Jalali M, Mahmoodi M, Mosallanezhad Z, Jalali R, Imanieh MH, Moosavian SP. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine 2020;48:102283. [DOI: 10.1016/j.ctim.2019.102283] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
27 Wu B, Liu X, Shi X, Han W, Wang C, Jiang L. Highly photoluminescent and temperature-sensitive P, N, B-co-doped carbon quantum dots and their highly sensitive recognition for curcumin. RSC Adv 2019;9:8340-9. [DOI: 10.1039/c9ra00183b] [Cited by in Crossref: 19] [Article Influence: 6.3] [Reference Citation Analysis]
28 Zhou J, Chen Y, Yu J, Li T, Lu Z, Chen Y, Zhang X, Ye F. The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment: A PRISMA-compliant network meta-analysis of randomized controlled trials. Medicine (Baltimore) 2021;100:e24884. [PMID: 33761646 DOI: 10.1097/MD.0000000000024884] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Bavarsad K, Riahi MM, Saadat S, Barreto G, Atkin SL, Sahebkar A. Protective effects of curcumin against ischemia-reperfusion injury in the liver. Pharmacological Research 2019;141:53-62. [DOI: 10.1016/j.phrs.2018.12.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
30 Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci 2017;13:965-1005. [PMID: 28883839 DOI: 10.5114/aoms.2017.69326] [Cited by in Crossref: 142] [Cited by in F6Publishing: 138] [Article Influence: 28.4] [Reference Citation Analysis]
31 Nouri-Vaskeh M, Malek Mahdavi A, Afshan H, Alizadeh L, Zarei M. Effect of curcumin supplementation on disease severity in patients with liver cirrhosis: A randomized controlled trial. Phytother Res 2020;34:1446-54. [PMID: 32017253 DOI: 10.1002/ptr.6620] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
32 Hosseini A, Hosseinzadeh H. Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review. Biomedicine & Pharmacotherapy 2018;99:411-21. [DOI: 10.1016/j.biopha.2018.01.072] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]
33 Kim Y, Clifton P. Curcumin, Cardiometabolic Health and Dementia. Int J Environ Res Public Health 2018;15:E2093. [PMID: 30250013 DOI: 10.3390/ijerph15102093] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
34 Saeidinia A, Keihanian F, Butler AE, Bagheri RK, Atkin SL, Sahebkar A. Curcumin in heart failure: A choice for complementary therapy? Pharmacol Res 2018;131:112-9. [PMID: 29550354 DOI: 10.1016/j.phrs.2018.03.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
35 Feng WW, Kuang SY, Tu C, Ma ZJ, Pang JY, Wang YH, Zang QC, Liu TS, Zhao YL, Xiao XH, Wang JB. Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin. Biomed Pharmacother 2018;99:325-33. [PMID: 29353208 DOI: 10.1016/j.biopha.2018.01.071] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
36 Salehi B, Stojanović-Radić Z, Matejić J, Sharifi-Rad M, Anil Kumar NV, Martins N, Sharifi-Rad J. The therapeutic potential of curcumin: A review of clinical trials. Eur J Med Chem 2019;163:527-45. [PMID: 30553144 DOI: 10.1016/j.ejmech.2018.12.016] [Cited by in Crossref: 129] [Cited by in F6Publishing: 107] [Article Influence: 32.3] [Reference Citation Analysis]
37 Farhood B, Mortezaee K, Goradel NH, Khanlarkhani N, Salehi E, Nashtaei MS, Najafi M, Sahebkar A. Curcumin as an anti-inflammatory agent: Implications to radiotherapy and chemotherapy. J Cell Physiol 2019;234:5728-40. [PMID: 30317564 DOI: 10.1002/jcp.27442] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 13.5] [Reference Citation Analysis]
38 Saraf-Bank S, Ahmadi A, Paknahad Z, Maracy M, Nourian M. Effects of curcumin supplementation on markers of inflammation and oxidative stress among healthy overweight and obese girl adolescents: A randomized placebo-controlled clinical trial. Phytother Res 2019;33:2015-22. [PMID: 31206225 DOI: 10.1002/ptr.6370] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
39 Swain MG, Wallace JL, Tyrrell DL, Cabanillas J, Aung SKH, Liu H, Finnie-Carvalho L, Shrestha G, Semple HA, Green FHY. Efficacy of a Peruvian Botanical Remedy (Sabell A4+) for Treating Liver Disease and Protecting Gastric Mucosal Integrity. Evid Based Complement Alternat Med 2019;2019:5486728. [PMID: 31781272 DOI: 10.1155/2019/5486728] [Reference Citation Analysis]
40 Chen Y, Chen C, Zhang X, He C, Zhao P, Li M, Fan T, Yan R, Lu Y, Lee RJ, Khan MW, Sarfraz M, Ma X, Yang T, Xiang G. Platinum complexes of curcumin delivered by dual-responsive polymeric nanoparticles improve chemotherapeutic efficacy based on the enhanced anti-metastasis activity and reduce side effects. Acta Pharm Sin B 2020;10:1106-21. [PMID: 32642416 DOI: 10.1016/j.apsb.2019.10.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
41 Singletary K. Turmeric: Potential Health Benefits. Nutr Today 2020;55:45-56. [DOI: 10.1097/nt.0000000000000392] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
42 Jarhahzadeh M, Alavinejad P, Farsi F, Husain D, Rezazadeh A. The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial. Diabetol Metab Syndr 2021;13:112. [PMID: 34663438 DOI: 10.1186/s13098-021-00731-7] [Reference Citation Analysis]
43 Saadati S, Sadeghi A, Mansour A, Yari Z, Poustchi H, Hedayati M, Hatami B, Hekmatdoost A. Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial. BMC Gastroenterol. 2019;19:133. [PMID: 31345163 DOI: 10.1186/s12876-019-1055-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
44 Ghanaatian N, Lashgari N, Abdolghaffari AH, Rajaee SM, Panahi Y, Barreto GE, Butler AE, Sahebkar A. Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets. J Cell Physiol 2019;234:12237-48. [DOI: 10.1002/jcp.27965] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
45 Al Sharif M, Alov P, Vitcheva V, Diukendjieva A, Mori M, Botta B, Tsakovska I, Pajeva I. Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox prediction. Toxicology and Applied Pharmacology 2017;337:45-66. [DOI: 10.1016/j.taap.2017.10.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
46 Patel SS, Acharya A, Ray RS, Agrawal R, Raghuwanshi R, Jain P. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Crit Rev Food Sci Nutr 2020;60:887-939. [PMID: 30632782 DOI: 10.1080/10408398.2018.1552244] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 20.0] [Reference Citation Analysis]
47 Komolafe O, Buzzetti E, Linden A, Best LM, Madden AM, Roberts D, Chase TJ, Fritche D, Freeman SC, Cooper NJ, Sutton AJ, Milne EJ, Wright K, Pavlov CS, Davidson BR, Tsochatzis E, Gurusamy KS. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database Syst Rev 2021;7:CD013157. [PMID: 34280304 DOI: 10.1002/14651858.CD013157.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Jin T. Mechanisms underlying the metabolic beneficial effect of curcumin intervention: Beyond anti-inflammation and anti-oxidative stress. Obesity Medicine 2019;13:1-5. [DOI: 10.1016/j.obmed.2018.11.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Akbari M, Lankarani KB, Tabrizi R, Ghayour-Mobarhan M, Peymani P, Ferns G, Ghaderi A, Asemi Z. The Effects of Curcumin on Weight Loss Among Patients With Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Pharmacol 2019;10:649. [PMID: 31249528 DOI: 10.3389/fphar.2019.00649] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
50 Pivari F, Mingione A, Brasacchio C, Soldati L. Curcumin and Type 2 Diabetes Mellitus: Prevention and Treatment. Nutrients 2019;11:E1837. [PMID: 31398884 DOI: 10.3390/nu11081837] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 19.3] [Reference Citation Analysis]
51 Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, Sahebkar A. Curcumin as a MicroRNA Regulator in Cancer: A Review. In: Nilius B, de Tombe P, Gudermann T, Jahn R, Lill R, Petersen OH, editors. Reviews of Physiology, Biochemistry and Pharmacology, Vol. 171. Cham: Springer International Publishing; 2016. pp. 1-38. [DOI: 10.1007/112_2016_3] [Cited by in Crossref: 130] [Cited by in F6Publishing: 132] [Article Influence: 21.7] [Reference Citation Analysis]
52 Mousavi SM, Milajerdi A, Varkaneh HK, Gorjipour MM, Esmaillzadeh A. The effects of curcumin supplementation on body weight, body mass index and waist circumference: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 2020;60:171-80. [PMID: 30373373 DOI: 10.1080/10408398.2018.1517724] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
53 Clark CC, Ghaedi E, Arab A, Pourmasoumi M, Hadi A. The effect of curcumin supplementation on circulating adiponectin: A systematic review and meta-analysis of randomized controlled trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019;13:2819-25. [DOI: 10.1016/j.dsx.2019.07.045] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
54 Bagheri H, Ghasemi F, Barreto GE, Rafiee R, Sathyapalan T, Sahebkar A. Effects of curcumin on mitochondria in neurodegenerative diseases. Biofactors 2020;46:5-20. [PMID: 31580521 DOI: 10.1002/biof.1566] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
55 Reyes-Fermín LM, Aparicio-Trejo OE, Avila-Rojas SH, Gómez-Sierra T, Martínez-Klimova E, Pedraza-Chaverri J. Natural antioxidants' effects on endoplasmic reticulum stress-related diseases. Food Chem Toxicol 2020;138:111229. [PMID: 32105807 DOI: 10.1016/j.fct.2020.111229] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
56 Mirhafez SR, Azimi-Nezhad M, Dehabeh M, Hariri M, Naderan RD, Movahedi A, Abdalla M, Sathyapalan T, Sahebkar A. The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. Adv Exp Med Biol 2021;1308:25-35. [PMID: 33861434 DOI: 10.1007/978-3-030-64872-5_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
57 Mohammadi E, Tamaddoni A, Qujeq D, Nasseri E, Zayeri F, Zand H, Gholami M, Mir SM. An investigation of the effects of curcumin on iron overload, hepcidin level, and liver function in β-thalassemia major patients: A double-blind randomized controlled clinical trial. Phytother Res 2018;32:1828-35. [PMID: 29806132 DOI: 10.1002/ptr.6118] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
58 Pricci M, Girardi B, Giorgio F, Losurdo G, Ierardi E, Di Leo A. Curcumin and Colorectal Cancer: From Basic to Clinical Evidences. Int J Mol Sci 2020;21:E2364. [PMID: 32235371 DOI: 10.3390/ijms21072364] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
59 Momtazi-Borojeni AA, Haftcheshmeh SM, Esmaeili SA, Johnston TP, Abdollahi E, Sahebkar A. Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmun Rev 2018;17:125-35. [PMID: 29180127 DOI: 10.1016/j.autrev.2017.11.016] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 8.6] [Reference Citation Analysis]
60 Hajavi J, Momtazi AA, Johnston TP, Banach M, Majeed M, Sahebkar A. Curcumin: A Naturally Occurring Modulator of Adipokines in Diabetes. J Cell Biochem 2017;118:4170-82. [DOI: 10.1002/jcb.26121] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
61 Hatamipour M, Ramezani M, Tabassi SAS, Johnston TP, Ramezani M, Sahebkar A. Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties. J Cell Physiol 2018;233:9247-60. [PMID: 30076727 DOI: 10.1002/jcp.27029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
62 T Krishnareddy N, Thomas JV, Nair SS, N Mulakal J, Maliakel BP, Krishnakumar IM. A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study. Biomed Res Int 2018;2018:9159281. [PMID: 30345312 DOI: 10.1155/2018/9159281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
63 Goodarzi R, Sabzian K, Shishehbor F, Mansoori A. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials: Turmeric/curcumin supplementation and liver enzymes. Phytotherapy Research 2019;33:561-70. [DOI: 10.1002/ptr.6270] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
64 Mokhtari‐zaer A, Marefati N, Atkin SL, Butler AE, Sahebkar A. The protective role of curcumin in myocardial ischemia–reperfusion injury. J Cell Physiol 2019;234:214-22. [DOI: 10.1002/jcp.26848] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
65 Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother 2017;85:102-12. [PMID: 27930973 DOI: 10.1016/j.biopha.2016.11.098] [Cited by in Crossref: 189] [Cited by in F6Publishing: 191] [Article Influence: 31.5] [Reference Citation Analysis]
66 Darvish Damavandi R, Shidfar F, Najafi M, Janani L, Masoodi M, Akbari-Fakhrabadi M, Dehnad A. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial. Phytother Res 2021;35:3145-56. [PMID: 33880813 DOI: 10.1002/ptr.6972] [Reference Citation Analysis]
67 Hariri M, Haghighatdoost F. Effect of Curcumin on Anthropometric Measures: A Systematic Review on Randomized Clinical Trials. J Am Coll Nutr 2018;37:215-22. [PMID: 29313748 DOI: 10.1080/07315724.2017.1392263] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
68 Pickich MB, Hargrove MW, Phillips CN, Healy JC, Moore AN, Roberts MD, Martin JS. Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis. BMC Res Notes 2019;12:496. [PMID: 31399137 DOI: 10.1186/s13104-019-4540-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
69 Mansour-Ghanaei F, Pourmasoumi M, Hadi A, Joukar F. Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials. Integr Med Res 2019;8:57-61. [PMID: 30949432 DOI: 10.1016/j.imr.2018.07.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
70 Barati N, Momtazi-Borojeni AA, Majeed M, Sahebkar A. Potential therapeutic effects of curcumin in gastric cancer. J Cell Physiol 2019;234:2317-28. [PMID: 30191991 DOI: 10.1002/jcp.27229] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
71 Różański G, Kujawski S, Newton JL, Zalewski P, Słomko J. Curcumin and Biochemical Parameters in Metabolic-Associated Fatty Liver Disease (MAFLD)-A Review. Nutrients 2021;13:2654. [PMID: 34444811 DOI: 10.3390/nu13082654] [Reference Citation Analysis]
72 Yan T, Yan N, Wang P, Xia Y, Hao H, Wang G, Gonzalez FJ. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. Acta Pharm Sin B 2020;10:3-18. [PMID: 31993304 DOI: 10.1016/j.apsb.2019.11.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
73 White CM, Lee JY. The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials. Pharm Pract (Granada) 2019;17:1350. [PMID: 31015871 DOI: 10.18549/PharmPract.2019.1.1350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
74 Melo ISVD, Santos AFD, Bueno NB. Curcumin or combined curcuminoids are effective in lowering the fasting blood glucose concentrations of individuals with dysglycemia: Systematic review and meta-analysis of randomized controlled trials. Pharmacological Research 2018;128:137-44. [DOI: 10.1016/j.phrs.2017.09.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
75 Simental-mendía LE, Pirro M, Gotto AM, Banach M, Atkin SL, Majeed M, Sahebkar A. Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition 2019;59:1178-87. [DOI: 10.1080/10408398.2017.1396201] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
76 Lim HJ, Kim M. EZH2 as a Potential Target for NAFLD Therapy. Int J Mol Sci 2020;21:E8617. [PMID: 33207561 DOI: 10.3390/ijms21228617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Naeini MB, Momtazi AA, Jaafari MR, Johnston TP, Barreto G, Banach M, Sahebkar A. Antitumor effects of curcumin: A lipid perspective. J Cell Physiol 2019;234:14743-58. [DOI: 10.1002/jcp.28262] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
78 Bavarsad K, Barreto GE, Hadjzadeh MA, Sahebkar A. Protective Effects of Curcumin Against Ischemia-Reperfusion Injury in the Nervous System. Mol Neurobiol 2019;56:1391-404. [PMID: 29948942 DOI: 10.1007/s12035-018-1169-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
79 Sharifi-Rad J, Rayess YE, Rizk AA, Sadaka C, Zgheib R, Zam W, Sestito S, Rapposelli S, Neffe-Skocińska K, Zielińska D, Salehi B, Setzer WN, Dosoky NS, Taheri Y, El Beyrouthy M, Martorell M, Ostrander EA, Suleria HAR, Cho WC, Maroyi A, Martins N. Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. Front Pharmacol 2020;11:01021. [PMID: 33041781 DOI: 10.3389/fphar.2020.01021] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 21.0] [Reference Citation Analysis]
80 Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Ž, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablík M, Wong ND, Banach M. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Nutr Rev 2017;75:731-67. [PMID: 28938795 DOI: 10.1093/nutrit/nux047] [Cited by in Crossref: 160] [Cited by in F6Publishing: 151] [Article Influence: 40.0] [Reference Citation Analysis]
81 Zhang S, Xu M, Zhang W, Liu C, Chen S. Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications. Int J Mol Sci 2021;22:6110. [PMID: 34204038 DOI: 10.3390/ijms22116110] [Reference Citation Analysis]
82 Cádiz Gurrea MDLL, Soares S, Jiménez FJL, Ochoa ÁF, Pinto D, Delerue-matos C, Carretero AS, Rodrigues F. Effects of Nutritional Supplements on Human Health. Nutraceuticals and Natural Product Pharmaceuticals. Elsevier; 2019. pp. 105-40. [DOI: 10.1016/b978-0-12-816450-1.00004-0] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
83 Hosseini SM, Ghayour Razmgah GR, Nematy M, Esmaily H, Yousefi M, Kamalinejad M, Mosavat SH. Efficacy of Black Seed (Nigella sativa) and Lemon Balm (Melissa officinalis) on Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. Iran Red Crescent Med J 2018;20. [DOI: 10.5812/ircmj.59183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
84 Zhi TX, Liu KQ, Cai KY, Zhao YC, Li ZW, Wang X, He XH, Sun XY. Anti-Lung Cancer Activities of 1,2,3-Triazole Curcumin Derivatives via Regulation of the MAPK/NF-κB/STAT3 Signaling Pathways. ChemMedChem 2021. [PMID: 34773680 DOI: 10.1002/cmdc.202100676] [Reference Citation Analysis]
85 Moghaddam NSA, Oskouie MN, Butler AE, Petit PX, Barreto GE, Sahebkar A. Hormetic effects of curcumin: What is the evidence? J Cell Physiol 2019;234:10060-71. [PMID: 30515809 DOI: 10.1002/jcp.27880] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
86 Mohammadi A, Blesso CN, Barreto GE, Banach M, Majeed M, Sahebkar A. Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent. J Nutr Biochem 2019;66:1-16. [PMID: 30660832 DOI: 10.1016/j.jnutbio.2018.12.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
87 Qin S, Huang L, Gong J, Shen S, Huang J, Ren H, Hu H. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutr J 2017;16:68. [PMID: 29020971 DOI: 10.1186/s12937-017-0293-y] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 15.0] [Reference Citation Analysis]
88 Zobeiri M, Parvizi F, Kalhori MR, Majnooni MB, Farzaei MH, Abdollahi M. Targeting miRNA by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver. Evid Based Complement Alternat Med 2021;2021:6641031. [PMID: 34426744 DOI: 10.1155/2021/6641031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Cicero AFG, Fogacci F, Colletti A. Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach. Food Funct 2017;8:2076-88. [DOI: 10.1039/c7fo00178a] [Cited by in Crossref: 87] [Cited by in F6Publishing: 35] [Article Influence: 17.4] [Reference Citation Analysis]
90 Parsamanesh N, Moossavi M, Bahrami A, Butler AE, Sahebkar A. Therapeutic potential of curcumin in diabetic complications. Pharmacological Research 2018;136:181-93. [DOI: 10.1016/j.phrs.2018.09.012] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 14.3] [Reference Citation Analysis]
91 Roehlen N, Crouchet E, Baumert TF. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020;9:E875. [PMID: 32260126 DOI: 10.3390/cells9040875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 24.5] [Reference Citation Analysis]
92 Cicero AFG, Sahebkar A, Fogacci F, Bove M, Giovannini M, Borghi C. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial. Eur J Nutr 2020;59:477-83. [PMID: 30796508 DOI: 10.1007/s00394-019-01916-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
93 Ganjali S, Blesso CN, Banach M, Pirro M, Majeed M, Sahebkar A. Effects of curcumin on HDL functionality. Pharmacological Research 2017;119:208-18. [DOI: 10.1016/j.phrs.2017.02.008] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 19.0] [Reference Citation Analysis]
94 Fereydouni N, Darroudi M, Movaffagh J, Shahroodi A, Butler AE, Ganjali S, Sahebkar A. Curcumin nanofibers for the purpose of wound healing. J Cell Physiol 2019;234:5537-54. [DOI: 10.1002/jcp.27362] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
95 Shahcheraghi SH, Zangui M, Lotfi M, Ghayour-Mobarhan M, Ghorbani A, Jaliani HZ, Sadeghnia HR, Sahebkar A. Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme. Curr Pharm Des 2019;25:333-42. [PMID: 30864499 DOI: 10.2174/1381612825666190313123704] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
96 Safari Z, Bagherniya M, Askari G, Sathyapalan T, Sahebkar A. The Effect of Curcumin Supplemsentation on Anthropometric Indices in Overweight and Obese Individuals: A Systematic Review of Randomized Controlled Trials. Adv Exp Med Biol 2021;1291:121-37. [PMID: 34331687 DOI: 10.1007/978-3-030-56153-6_7] [Reference Citation Analysis]
97 Tabeshpour J, Hashemzaei M, Sahebkar A. The regulatory role of curcumin on platelet functions. J Cell Biochem 2018;119:8713-22. [PMID: 30098070 DOI: 10.1002/jcb.27192] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
98 Villarroel-Vicente C, Gutiérrez-Palomo S, Ferri J, Cortes D, Cabedo N. Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview. Eur J Med Chem 2021;221:113535. [PMID: 33992930 DOI: 10.1016/j.ejmech.2021.113535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
99 Ghosh SS, He H, Wang J, Gehr TW, Ghosh S. Curcumin-mediated regulation of intestinal barrier function: The mechanism underlying its beneficial effects. Tissue Barriers 2018;6:e1425085. [PMID: 29420166 DOI: 10.1080/21688370.2018.1425085] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
100 Simón J, Casado-Andrés M, Goikoetxea-Usandizaga N, Serrano-Maciá M, Martínez-Chantar ML. Nutraceutical Properties of Polyphenols against Liver Diseases. Nutrients 2020;12:E3517. [PMID: 33203174 DOI: 10.3390/nu12113517] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
101 Hatamipour M, Ramezani M, Tabassi SAS, Johnston TP, Sahebkar A. Demethoxycurcumin: A naturally occurring curcumin analogue for treating non-cancerous diseases. J Cell Physiol 2019;234:19320-30. [PMID: 31344992 DOI: 10.1002/jcp.28626] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
102 Kunnumakkara AB, Harsha C, Banik K, Vikkurthi R, Sailo BL, Bordoloi D, Gupta SC, Aggarwal BB. Is curcumin bioavailability a problem in humans: lessons from clinical trials. Expert Opinion on Drug Metabolism & Toxicology 2019;15:705-33. [DOI: 10.1080/17425255.2019.1650914] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 20.3] [Reference Citation Analysis]
103 Razavi BM, Ghasemzadeh Rahbardar M, Hosseinzadeh H. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents. Phytother Res 2021. [PMID: 34312922 DOI: 10.1002/ptr.7224] [Reference Citation Analysis]
104 Oliveira S, Monteiro-Alfredo T, Silva S, Matafome P. Curcumin derivatives for Type 2 Diabetes management and prevention of complications. Arch Pharm Res 2020;43:567-81. [PMID: 32557163 DOI: 10.1007/s12272-020-01240-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
105 Cicero AF, Colletti A. Food and plant bioactives for reducing cardiometabolic disease: How does the evidence stack up? Trends in Food Science & Technology 2017;69:192-202. [DOI: 10.1016/j.tifs.2017.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
106 Abd El-Hameed NM, Abd El-Aleem SA, Khattab MA, Ali AH, Mohammed HH. Curcumin activation of nuclear factor E2-related factor 2 gene (Nrf2): Prophylactic and therapeutic effect in nonalcoholic steatohepatitis (NASH). Life Sci 2021;285:119983. [PMID: 34599938 DOI: 10.1016/j.lfs.2021.119983] [Reference Citation Analysis]
107 Panahi Y, Fazlolahzadeh O, Atkin SL, Majeed M, Butler AE, Johnston TP, Sahebkar A. Evidence of curcumin and curcumin analogue effects in skin diseases: A narrative review. J Cell Physiol 2019;234:1165-78. [PMID: 30073647 DOI: 10.1002/jcp.27096] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
108 Forouzanfar F, Majeed M, Jamialahmadi T, Sahebkar A. Curcumin: A Review of Its Effects on Epilepsy. Adv Exp Med Biol 2021;1291:363-73. [PMID: 34331701 DOI: 10.1007/978-3-030-56153-6_21] [Reference Citation Analysis]
109 Mahdavi A, Bagherniya M, Fakheran O, Reiner Ž, Xu S, Sahebkar A. Medicinal plants and bioactive natural compounds as inhibitors of HMG-CoA reductase: A literature review. Biofactors 2020;46:906-26. [PMID: 33053603 DOI: 10.1002/biof.1684] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
110 Yuan F, Dong H, Gong J, Wang D, Hu M, Huang W, Fang K, Qin X, Qiu X, Yang X, Lu F. A Systematic Review and Meta-analysis of Randomized Controlled Trials on the Effects of Turmeric and Curcuminoids on Blood Lipids in Adults with Metabolic Diseases. Adv Nutr 2019;10:791-802. [PMID: 31212316 DOI: 10.1093/advances/nmz021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
111 Baziar N, Parohan M. The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res 2020;34:464-74. [PMID: 31799714 DOI: 10.1002/ptr.6542] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
112 Feldman F, Koudoufio M, Desjardins Y, Spahis S, Delvin E, Levy E. Efficacy of Polyphenols in the Management of Dyslipidemia: A Focus on Clinical Studies. Nutrients 2021;13:672. [PMID: 33669729 DOI: 10.3390/nu13020672] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
113 Panahi Y, Kianpour P, Mohtashami R, Soflaei SS, Sahebkar A. Efficacy of phospholipidated curcumin in nonalcoholic fatty liver disease: a clinical study. J Asian Nat Prod Res 2019;21:798-805. [PMID: 30415581 DOI: 10.1080/10286020.2018.1505873] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
114 Jazayeri SF, Ghods R, Hashem Dabaghian F, Shojaii A, Moravej SAA, Khadem E, Seyedian SS. The Efficacy of Plantago major Seed on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial. Evid Based Complement Alternat Med 2021;2021:6693887. [PMID: 33854559 DOI: 10.1155/2021/6693887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Badakhshi Y, Jin T. Current understanding and controversies on the clinical implications of fibroblast growth factor 21. Crit Rev Clin Lab Sci 2021;58:311-28. [PMID: 33382006 DOI: 10.1080/10408363.2020.1864278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Ali SA, Singh G, Datusalia AK. Potential therapeutic applications of phytoconstituents as immunomodulators: Pre-clinical and clinical evidences. Phytother Res 2021;35:3702-31. [PMID: 33734511 DOI: 10.1002/ptr.7068] [Reference Citation Analysis]
117 Ghazimoradi M, Saberi-Karimian M, Mohammadi F, Sahebkar A, Tavallaie S, Safarian H, Ferns GA, Ghayour-Mobarhan M, Moohebati M, Esmaeili H, Ahmadinejad M. The Effects of Curcumin and Curcumin-Phospholipid Complex on the Serum Pro-oxidant-Antioxidant Balance in Subjects with Metabolic Syndrome. Phytother Res 2017;31:1715-21. [PMID: 28840615 DOI: 10.1002/ptr.5899] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
118 Fu K, Wang C, Ma C, Zhou H, Li Y. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity. Front Pharmacol 2021;12:771459. [PMID: 34803712 DOI: 10.3389/fphar.2021.771459] [Reference Citation Analysis]
119 Farzaei MH, Zobeiri M, Parvizi F, El-Senduny FF, Marmouzi I, Coy-Barrera E, Naseri R, Nabavi SM, Rahimi R, Abdollahi M. Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective. Nutrients 2018;10:E855. [PMID: 29966389 DOI: 10.3390/nu10070855] [Cited by in Crossref: 105] [Cited by in F6Publishing: 89] [Article Influence: 26.3] [Reference Citation Analysis]
120 Koboziev I, Scoggin S, Gong X, Mirzaei P, Zabet-Moghaddam M, Yosofvand M, Moussa H, Jones-Hall Y, Moustaid-Moussa N. Effects of Curcumin in a Mouse Model of Very High Fat Diet-Induced Obesity. Biomolecules 2020;10:E1368. [PMID: 32992936 DOI: 10.3390/biom10101368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
121 Panahi Y, Khalili N, Sahebi E, Namazi S, Karimian MS, Majeed M, Sahebkar A. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacol 2017;25:25-31. [DOI: 10.1007/s10787-016-0301-4] [Cited by in Crossref: 104] [Cited by in F6Publishing: 96] [Article Influence: 17.3] [Reference Citation Analysis]
122 Luber RP, Rentsch C, Lontos S, Pope JD, Aung AK, Schneider HG, Kemp W, Roberts SK, Majeed A. Turmeric induced liver injury: A report of two cases. Case Reports Hepatol. 2019;2019:6741213. [PMID: 31214366 DOI: 10.1155/2019/6741213] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
123 Derosa G, Maffioli P, Simental-Mendía LE, Bo S, Sahebkar A. Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 2016;111:394-404. [PMID: 27392742 DOI: 10.1016/j.phrs.2016.07.004] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 12.8] [Reference Citation Analysis]
124 Akaberi M, Sahebkar A, Emami SA. Turmeric and Curcumin: From Traditional to Modern Medicine. Adv Exp Med Biol 2021;1291:15-39. [PMID: 34331682 DOI: 10.1007/978-3-030-56153-6_2] [Reference Citation Analysis]
125 Jafarirad S, Mansoori A, Adineh A, Panahi Y, Hadi A, Goodarzi R. Does Turmeric/curcumin Supplementation Change Anthropometric Indices in Patients with Non-alcoholic Fatty Liver Disease? A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clin Nutr Res 2019;8:196-208. [PMID: 31384598 DOI: 10.7762/cnr.2019.8.3.196] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
126 Saheb M, Fereydouni N, Nemati S, Barreto GE, Johnston TP, Sahebkar A. Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects. J Cell Physiol 2019;234:12325-40. [PMID: 30697728 DOI: 10.1002/jcp.28024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
127 Mortezaee K, Salehi E, Mirtavoos-Mahyari H, Motevaseli E, Najafi M, Farhood B, Rosengren RJ, Sahebkar A. Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy. J Cell Physiol 2019;234:12537-50. [PMID: 30623450 DOI: 10.1002/jcp.28122] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 21.7] [Reference Citation Analysis]
128 Delli Bovi AP, Marciano F, Mandato C, Siano MA, Savoia M, Vajro P. Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review. Front Med (Lausanne) 2021;8:595371. [PMID: 33718398 DOI: 10.3389/fmed.2021.595371] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
129 Teymouri M, Pirro M, Johnston TP, Sahebkar A. Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. Biofactors 2017;43:331-46. [PMID: 27896883 DOI: 10.1002/biof.1344] [Cited by in Crossref: 104] [Cited by in F6Publishing: 73] [Article Influence: 17.3] [Reference Citation Analysis]
130 Shakeri A, Cicero AFG, Panahi Y, Mohajeri M, Sahebkar A. Curcumin: A naturally occurring autophagy modulator. J Cell Physiol 2019;234:5643-54. [PMID: 30239005 DOI: 10.1002/jcp.27404] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 17.3] [Reference Citation Analysis]
131 Perumpail BJ, Li AA, Iqbal U, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A. Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD. Diseases 2018;6:E80. [PMID: 30201879 DOI: 10.3390/diseases6030080] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
132 Azhdari M, Karandish M, Mansoori A. Metabolic benefits of curcumin supplementation in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Phytother Res 2019;33:1289-301. [PMID: 30941814 DOI: 10.1002/ptr.6323] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
133 Hamzehzadeh L, Atkin SL, Majeed M, Butler AE, Sahebkar A. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway. J Cell Physiol 2018;233:6530-7. [PMID: 29693253 DOI: 10.1002/jcp.26620] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
134 Liu K, Luo M, Wei S. The Bioprotective Effects of Polyphenols on Metabolic Syndrome against Oxidative Stress: Evidences and Perspectives. Oxid Med Cell Longev 2019;2019:6713194. [PMID: 31885810 DOI: 10.1155/2019/6713194] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
135 Zangui M, Atkin SL, Majeed M, Sahebkar A. Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-art. Pharmacological Research 2019;141:343-56. [DOI: 10.1016/j.phrs.2019.01.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
136 Shen X, Guo H, Xu J, Wang J. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease. J Cell Physiol 2019;234:18169-79. [PMID: 30908654 DOI: 10.1002/jcp.28450] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
137 Amerikanou C, Kanoni S, Kaliora AC, Barone A, Bjelan M, D'auria G, Gioxari A, Gosalbes MJ, Mouchti S, Stathopoulou MG, Soriano B, Stojanoski S, Banerjee R, Halabalaki M, Mikropoulou EV, Kannt A, Lamont J, Llorens C, Marascio F, Marascio M, Roig FJ, Smyrnioudis I, Varlamis I, Visvikis‐siest S, Vukic M, Milic N, Medic‐stojanoska M, Cesarini L, Campolo J, Gastaldelli A, Deloukas P, Trivella MG, Francino MP, Dedoussis GV; MAST4HEALTH consortium. Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial. Mol Nutr Food Res 2021;65:2001178. [DOI: 10.1002/mnfr.202001178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
138 Panahi Y, Khalili N, Sahebi E, Namazi S, Reiner Ž, Majeed M, Sahebkar A. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. Complementary Therapies in Medicine 2017;33:1-5. [DOI: 10.1016/j.ctim.2017.05.006] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
139 Saraf-Bank S, Ahmadi A, Paknahad Z, Maracy M, Nourian M. Effects of curcumin on cardiovascular risk factors in obese and overweight adolescent girls: a randomized clinical trial. Sao Paulo Med J 2019;137:414-22. [PMID: 31691723 DOI: 10.1590/1516-3180.2018.0454120419] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
140 Huang J, Qin S, Huang L, Tang Y, Ren H, Hu H. Efficacy and safety of Rhizoma curcumea longae with respect to improving the glucose metabolism of patients at risk for cardiovascular disease: a meta-analysis of randomised controlled trials. J Hum Nutr Diet 2019;32:591-606. [PMID: 30983042 DOI: 10.1111/jhn.12648] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
141 Soleimani V, Sahebkar A, Hosseinzadeh H. Turmeric ( Curcuma longa ) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytotherapy Research 2018;32:985-95. [DOI: 10.1002/ptr.6054] [Cited by in Crossref: 165] [Cited by in F6Publishing: 127] [Article Influence: 41.3] [Reference Citation Analysis]
142 Asgary S, Rastqar A, Keshvari M. Functional Food and Cardiovascular Disease Prevention and Treatment: A Review. J Am Coll Nutr 2018;37:429-55. [PMID: 29528772 DOI: 10.1080/07315724.2017.1410867] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
143 Dong F, Zhang Y, Huang Y, Wang Y, Zhang G, Hu X, Wang J, Chen J, Bao Z. Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial. Sci Rep 2016;6:36783. [PMID: 27830836 DOI: 10.1038/srep36783] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
144 Panahi Y, Valizadegan G, Ahamdi N, Ganjali S, Majeed M, Sahebkar A. Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial. J Cell Biochem 2019;120:15989-96. [PMID: 31168845 DOI: 10.1002/jcb.28877] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
145 Seo SG, Ahn YJ, Jin MH, Kang NG, Cho HS. Curcuma longa enhances IFN-γ secretion by natural killer cells through cytokines secreted from macrophages. J Food Sci 2021;86:3492-504. [PMID: 34250593 DOI: 10.1111/1750-3841.15821] [Reference Citation Analysis]
146 Masoodi M, Mahdiabadi MA, Mokhtare M, Agah S, Kashani AHF, Rezadoost AM, Sabzikarian M, Talebi A, Sahebkar A. The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients' self-reported well-being: A randomized double-blind controlled trial. J Cell Biochem 2018;119:9552-9. [PMID: 30132960 DOI: 10.1002/jcb.27273] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
147 Schiano E, Annunziata G, Ciampaglia R, Iannuzzo F, Maisto M, Tenore GC, Novellino E. Bioactive Compounds for the Management of Hypertriglyceridemia: Evidence From Clinical Trials and Putative Action Targets. Front Nutr 2020;7:586178. [PMID: 33330588 DOI: 10.3389/fnut.2020.586178] [Reference Citation Analysis]
148 Atkin SL, Katsiki N, Derosa G, Maffioli P, Sahebkar A. Curcuminoids Lower Plasma Leptin Concentrations: A Meta-analysis: Curcumin Effect on Leptin. Phytother Res 2017;31:1836-41. [DOI: 10.1002/ptr.5905] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
149 Li C, Miao X, Li F, Adhikari BK, Liu Y, Sun J, Zhang R, Cai L, Liu Q, Wang Y. Curcuminoids: Implication for inflammation and oxidative stress in cardiovascular diseases. Phytother Res 2019;33:1302-17. [PMID: 30834628 DOI: 10.1002/ptr.6324] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
150 Ramezani M, Hatamipour M, Sahebkar A. Promising anti-tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue. J Cell Physiol. 2018;233:880-887. [PMID: 28075008 DOI: 10.1002/jcp.25795] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
151 Ibrahim KG, Chivandi E, Nkomozepi P, Matumba MG, Mukwevho E, Erlwanger KH. The long-term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high-fructose-fed adolescent rats. Physiol Rep 2019;7:e14032. [PMID: 30912307 DOI: 10.14814/phy2.14032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Saadati S, Hatami B, Yari Z, Shahrbaf MA, Eghtesad S, Mansour A, Poustchi H, Hedayati M, Aghajanpoor-Pasha M, Sadeghi A, Hekmatdoost A. The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease. Eur J Clin Nutr 2019;73:441-9. [PMID: 30610213 DOI: 10.1038/s41430-018-0382-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
153 Xu Y, Guo W, Zhang C, Chen F, Tan HY, Li S, Wang N, Feng Y. Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application. Front Pharmacol 2020;11:601. [PMID: 32477116 DOI: 10.3389/fphar.2020.00601] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
154 Zendedel E, Butler AE, Atkin SL, Sahebkar A. Impact of curcumin on sirtuins: A review. J Cell Biochem 2018;119:10291-300. [PMID: 30145851 DOI: 10.1002/jcb.27371] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
155 Karandish M, Mozaffari-Khosravi H, Mohammadi SM, Azhdari M, Cheraghian B. Evaluation of the effect of curcumin and zinc co-supplementation on glycemic measurements, lipid profiles, and inflammatory and antioxidant biomarkers in overweight or obese prediabetic patients: a study protocol for a randomized double-blind placebo-controlled phase 2 clinical trial. Trials 2020;21:991. [PMID: 33256795 DOI: 10.1186/s13063-020-04923-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Poolsup N, Suksomboon N, Kurnianta PDM, Deawjaroen K. Effects of curcumin on glycemic control and lipid profile in prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis. PLoS One 2019;14:e0215840. [PMID: 31013312 DOI: 10.1371/journal.pone.0215840] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
157 Pancholi V, Smina TP, Kunnumakkara AB, Maliakel B, Krishnakumar IM. Safety assessment of a highly bioavailable curcumin-galactomannoside complex (CurQfen) in healthy volunteers, with a special reference to the recent hepatotoxic reports of curcumin supplements: A 90-days prospective study. Toxicol Rep 2021;8:1255-64. [PMID: 34195017 DOI: 10.1016/j.toxrep.2021.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
158 Zahedi H, Hosseinzadeh-Attar MJ, Sahebkar A, Ranjbar SH, Najafi A, Hosseini S, Qorbani M, Ahmadi A, Ardehali SH, Moravvej H, Pourmand G, Norouzy A, Shadnoush M. Therapeutic effects of supplementation with Curcuminoids in critically ill patients receiving enteral nutrition: a randomized controlled trial protocol. J Diabetes Metab Disord 2020;19:1609-14. [PMID: 33553039 DOI: 10.1007/s40200-019-00451-w] [Reference Citation Analysis]
159 Li HY, Gan RY, Shang A, Mao QQ, Sun QC, Wu DT, Geng F, He XQ, Li HB. Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application. Oxid Med Cell Longev 2021;2021:6621644. [PMID: 33728021 DOI: 10.1155/2021/6621644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
160 Lee ES, Kwon MH, Kim HM, Woo HB, Ahn CM, Chung CH. Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity. Metabolism 2020;103:154015. [PMID: 31758951 DOI: 10.1016/j.metabol.2019.154015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
161 Saberi-karimian M, Keshvari M, Ghayour-mobarhan M, Salehizadeh L, Rahmani S, Behnam B, Jamialahmadi T, Asgary S, Sahebkar A. Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Complementary Therapies in Medicine 2020;49:102322. [DOI: 10.1016/j.ctim.2020.102322] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 12.5] [Reference Citation Analysis]
162 Forouzanfar F, Barreto G, Majeed M, Sahebkar A. Modulatory effects of curcumin on heat shock proteins in cancer: A promising therapeutic approach. BioFactors 2019;45:631-40. [DOI: 10.1002/biof.1522] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
163 Liu Y, Cheng F, Luo Y, Zhan Z, Hu P, Ren H, Tang H, Peng M. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway. Biomed Res Int 2017;2017:8234507. [PMID: 28770225 DOI: 10.1155/2017/8234507] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
164 Shabalala SC, Dludla PV, Mabasa L, Kappo AP, Basson AK, Pheiffer C, Johnson R. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomed Pharmacother 2020;131:110785. [PMID: 33152943 DOI: 10.1016/j.biopha.2020.110785] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
165 Wei Z, Liu N, Tantai X, Xing X, Xiao C, Chen L, Wang J. The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Hepatol Int 2019;13:302-13. [DOI: 10.1007/s12072-018-9910-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
166 Rezaee R, Momtazi AA, Monemi A, Sahebkar A. Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity. Pharmacological Research 2017;117:218-27. [DOI: 10.1016/j.phrs.2016.12.037] [Cited by in Crossref: 100] [Cited by in F6Publishing: 95] [Article Influence: 20.0] [Reference Citation Analysis]
167 Karimian MS, Pirro M, Majeed M, Sahebkar A. Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine & Growth Factor Reviews 2017;33:55-63. [DOI: 10.1016/j.cytogfr.2016.10.001] [Cited by in Crossref: 93] [Cited by in F6Publishing: 93] [Article Influence: 18.6] [Reference Citation Analysis]
168 Stromsnes K, Lagzdina R, Olaso-Gonzalez G, Gimeno-Mallench L, Gambini J. Pharmacological Properties of Polyphenols: Bioavailability, Mechanisms of Action, and Biological Effects in In Vitro Studies, Animal Models, and Humans. Biomedicines 2021;9:1074. [PMID: 34440278 DOI: 10.3390/biomedicines9081074] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A. Immune modulation by curcumin: The role of interleukin-10.Crit Rev Food Sci Nutr. 2019;59:89-101. [PMID: 28799796 DOI: 10.1080/10408398.2017.1358139] [Cited by in Crossref: 125] [Cited by in F6Publishing: 118] [Article Influence: 25.0] [Reference Citation Analysis]
170 Vargas-Pozada EE, Muriel P. Herbal medicines for the liver: from bench to bedside. Eur J Gastroenterol Hepatol 2020;32:148-58. [PMID: 31895207 DOI: 10.1097/MEG.0000000000001485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
171 Alidadi M, Sahebkar A, Eslami S, Vakilian F, Jarahi L, Alinezhad-Namaghi M, Arabi SM, Vakili S, Tohidinezhad F, Nikooiyan Y, Norouzy A. The Effect of Curcumin Supplementation on Pulse Wave Velocity in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Adv Exp Med Biol 2021;1308:1-11. [PMID: 33861432 DOI: 10.1007/978-3-030-64872-5_1] [Reference Citation Analysis]
172 Najafi M, Mortezaee K, Rahimifard M, Farhood B, Haghi-aminjan H. The role of curcumin/curcuminoids during gastric cancer chemotherapy: A systematic review of non-clinical study. Life Sciences 2020;257:118051. [DOI: 10.1016/j.lfs.2020.118051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
173 Meroni M, Longo M, Rustichelli A, Dongiovanni P. Nutrition and Genetics in NAFLD: The Perfect Binomium. Int J Mol Sci 2020;21:E2986. [PMID: 32340286 DOI: 10.3390/ijms21082986] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
174 Alsharif FJ, Almuhtadi YA. The Effect of Curcumin Supplementation on Anthropometric Measures among Overweight or Obese Adults. Nutrients 2021;13:680. [PMID: 33672680 DOI: 10.3390/nu13020680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Hassanzadeh K, Buccarello L, Dragotto J, Mohammadi A, Corbo M, Feligioni M. Obstacles against the Marketing of Curcumin as a Drug. Int J Mol Sci 2020;21:E6619. [PMID: 32927725 DOI: 10.3390/ijms21186619] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
176 Sohaei S, Amani R, Tarrahi MJ, Ghasemi-tehrani H. The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial. Complementary Therapies in Medicine 2019;47:102201. [DOI: 10.1016/j.ctim.2019.102201] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
177 Lee EJ, Hwang JS, Kang ES, Lee SB, Hur J, Lee WJ, Choi MJ, Kim JT, Seo HG. Nanoemulsions improve the efficacy of turmeric in palmitate- and high fat diet-induced cellular and animal models. Biomed Pharmacother 2019;110:181-9. [PMID: 30469082 DOI: 10.1016/j.biopha.2018.11.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
178 Bagherniya M, Nobili V, Blesso CN, Sahebkar A. Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review. Pharmacol Res 2018;130:213-40. [PMID: 29287685 DOI: 10.1016/j.phrs.2017.12.020] [Cited by in Crossref: 73] [Cited by in F6Publishing: 64] [Article Influence: 14.6] [Reference Citation Analysis]
179 Farshbaf-Khalili A, Farajnia S, Pourzeinali S, Shakouri SK, Salehi-Pourmehr H. The effect of nanomicelle curcumin supplementation and Nigella sativa oil on the expression level of miRNA-21, miRNA-422a, and miRNA-503 gene in postmenopausal women with low bone mass density: A randomized, triple-blind, placebo-controlled clinical trial with factorial design. Phytother Res 2021. [PMID: 34496087 DOI: 10.1002/ptr.7259] [Reference Citation Analysis]
180 Abenavoli L, Larussa T, Corea A, Procopio AC, Boccuto L, Dallio M, Federico A, Luzza F. Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease. Nutrients 2021;13:494. [PMID: 33546130 DOI: 10.3390/nu13020494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
181 Shan D, Wang J, Di Q, Jiang Q, Xu Q. Steatosis induced by nonylphenol in HepG2 cells and the intervention effect of curcumin. Food Funct 2021. [PMID: 34904613 DOI: 10.1039/d1fo02481g] [Reference Citation Analysis]
182 Peng J. The Pharmacological Targets and Clinical Evidence of Natural Products With Anti-hepatic Inflammatory Properties. Front Pharmacol 2018;9:455. [PMID: 29922155 DOI: 10.3389/fphar.2018.00455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
183 Oskouie MN, Aghili Moghaddam NS, Butler AE, Zamani P, Sahebkar A. Therapeutic use of curcumin‐encapsulated and curcumin‐primed exosomes. J Cell Physiol 2019;234:8182-91. [DOI: 10.1002/jcp.27615] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
184 Bahrami A, Atkin SL, Majeed M, Sahebkar A. Effects of curcumin on hypoxia-inducible factor as a new therapeutic target. Pharmacol Res 2018;137:159-69. [PMID: 30315965 DOI: 10.1016/j.phrs.2018.10.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
185 Bian W, Wang X, Wang Y, Yang H, Huang J, Cai Z, Choi MMF. Boron and nitrogen co-doped carbon dots as a sensitive fluorescent probe for the detection of curcumin. Luminescence 2018;33:174-80. [DOI: 10.1002/bio.3390] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 7.4] [Reference Citation Analysis]
186 Momtazi AA, Banach M, Pirro M, Katsiki N, Sahebkar A. Regulation of PCSK9 by nutraceuticals. Pharmacol Res 2017;120:157-69. [PMID: 28363723 DOI: 10.1016/j.phrs.2017.03.023] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 12.0] [Reference Citation Analysis]
187 Shaker Shiran H, Baghbanbashi M, Ghazizadeh Ahsaie F, Pazuki G. Study of curcumin partitioning in polymer-salt aqueous two phase systems. Journal of Molecular Liquids 2020;303:112629. [DOI: 10.1016/j.molliq.2020.112629] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]